только для медицинских специалистов

Консультант врача

Электронная медицинская библиотека

Раздел 10 / 10
Страница 1 / 1

Список литературы

 

  1. A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021 [Internet].              [cited             2024              Nov              8].              Available              from: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition- Clinical_case_definition-2021.1
  2. Nalbandian A, Sehgal K, Gupta A, Madhavan M V., McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nature Medicine 2021 27:4 [Internet]. 2021 Mar 22 [cited 2024 Nov 8];27(4):601–15. Available from: https://www.nature.com/articles/s41591-021-01283-z
  3. Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry [Internet]. 2020 Jul 1 [cited 2024 Nov 8];7(7):611–27. Available from: http://www.thelancet.com/article/S2215036620302030/fulltext
  4. Chritinin DF, Shamrey VK, Litvinenko I V., Kurasov ES, Tsygan N V., Vainshenker YI. Psikhologicheskie, psikhiatricheskie i nevrologicheskie aspekty COVID-19. Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(4 Vyp 2):44–51.
  5. Munblit D, Bobkova P, Spiridonova E, Shikhaleva A, Gamirova A, Blyuss O, et al. Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19. Clin Exp Allergy [Internet]. 2021 Sep 1 [cited 2024 Nov 8];51(9):1107–20. Available from: https://pubmed.ncbi.nlm.nih.gov/34351016/
  6. Mazza MG, De Lorenzo R, Conte C, Poletti S, Vai B, Bollettini I, et al. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain Behav Immun [Internet]. 2020 Oct 1 [cited 2024 Nov 12];89:594–600. Available from: https://pubmed.ncbi.nlm.nih.gov/32738287/
  7. Richard SA, Pollett SD, Fries AC, Berjohn CM, Maves RC, Lalani T, et al. Persistent COVID- 19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS- CoV-2 Infection. JAMA Netw Open [Internet]. 2023 Jan 3 [cited 2024 Nov 12];6(1):e2251360–e2251360.                                                                       Available                                       from: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2800554
  8. Levine RL. Addressing the Long-term Effects of COVID-19. JAMA [Internet]. 2022 Sep 6 [cited                        2024              Nov               12];328(9):823–4.               Available               from: https://jamanetwork.com/journals/jama/fullarticle/2795139
  9. Richard SA, Pollett SD, Fries AC, Berjohn CM, Maves RC, Lalani T, et al. Persistent COVID- 19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS- CoV-2 Infection. JAMA Netw Open [Internet]. 2023 Jan 3 [cited 2024 Nov 12];6(1):e2251360–e2251360.                                                                       Available                                       from: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2800554
  10. Hall PA, Sheeran P, Fong GT, Cheah CSL, Oremus M, Liu-Ambrose T, et al. Biobehavioral Aspects of the COVID-19 Pandemic: A Review. Psychosom Med [Internet]. 2021 May 1 [cited 2024 Nov 12];83(4):309–21. Available from: https://pubmed.ncbi.nlm.nih.gov/33790201/
  11. Schou TM, Joca S, Wegener G, Bay-Richter C. Psychiatric and neuropsychiatric sequelae of COVID-19 – A systematic review. Brain Behav Immun [Internet]. 2021 Oct 1 [cited 2024 Nov 12];97:328. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC8363196/
  12. Daly M, Sutin AR, Robinson E. Longitudinal changes in mental health and the COVID-19 pandemic: evidence from the UK Household Longitudinal Study. Psychol Med [Internet]. 2022 Oct 13 [cited 2024 Nov 12];52(13):2549–58. Available from: https://pubmed.ncbi.nlm.nih.gov/33183370/
  13. Xiong J, Lipsitz O, Nasri F, Lui LMW, Gill H, Phan L, et al. Impact of COVID-19 pandemic on mental health in the general population: A systematic review. J Affect Disord [Internet]. 2020 Dec 1 [cited 2024 Nov 12];277:55. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC7413844/
  14. Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature 2021 594:7862 [Internet]. 2021 Apr 22 [cited 2024 Nov 12];594(7862):259–64. Available from: https://www.nature.com/articles/s41586-021-03553- 9
  15. Heneka MT, Golenbock D, Latz E, Morgan D, Brown R. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimers Res Ther [Internet]. 2020 Jun 4 [cited 2024 Nov 12];12(1). Available from: https://pubmed.ncbi.nlm.nih.gov/32498691/
  16. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol [Internet]. 2020 Jun 1              [cited            2024            Nov            12];77(6):683–90.            Available            from: https://pubmed.ncbi.nlm.nih.gov/32275288/
  17. Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? Lancet Neurol [Internet]. 2020 May 1 [cited 2024 Nov 12];19(5):383–4. Available from: https://pubmed.ncbi.nlm.nih.gov/32246917/
  18. Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry [Internet]. 2021 Feb 1 [cited 2023 Dec 1];8(2):130. Available from: /pmc/articles/PMC7820108/
  19. Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, et al. Neurologic Features in Severe SARS-CoV-2 Infection. N Engl J Med [Internet]. 2020 Jun 4 [cited 2024 Nov 12];382(23):2268–70. Available from: https://pubmed.ncbi.nlm.nih.gov/32294339/
  20. Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, et al. Neurological associations of COVID-19. Lancet Neurol [Internet]. 2020 Sep 1 [cited 2024 Nov 12];19(9):767–83. Available from: https://pubmed.ncbi.nlm.nih.gov/32622375/
  21. Taquet M, Holmes EA, Harrison PJ. Depression and anxiety disorders during the COVID-19 pandemic: knowns and unknowns. Lancet [Internet]. 2021 Nov 6 [cited 2024 Jul 31];398(10312):1665–6. Available from: https://pubmed.ncbi.nlm.nih.gov/34634251/
  22. Raffa RB., Amantea Diana. Naturally occurring benzodiazepines, endozepines, and their receptors : implications for benzodiazepine therapy and withdrawal [Internet]. CRC Press; 2022 [cited 2024 Nov 12]. Available from: https://www.routledge.com/Naturally-Occurring- Benzodiazepines-Endozepines-and-their-Receptors-Implications-for-Benzodiazepine- Therapy-and-Withdrawal/Raffa-Amantea/p/book/9780367409067
  23. Guina J, Rossetter SR, Derhodes BJ, Nahhas RW, Welton RS. Winner of resident paper award 2014: Benzodiazepines for PTSD: A systematic review and meta-analysis. J Psychiatr Pract [Internet]. 2015 Jul 1 [cited 2024 Nov 12];21(4):281–303. Available from: https://journals.lww.com/practicalpsychiatry/fulltext/2015/07000/benzodiazepines_for_ptsd_ _a_systematic_review_and.6.aspx
  24. Shanthanna H, Nelson AM, Kissoon N, Narouze S. The COVID-19 pandemic and its consequences for chronic pain: a narrative review. Anaesthesia [Internet]. 2022 Sep 1 [cited 2023 Dec 5];77(9):1039–50. Available from: https://pubmed.ncbi.nlm.nih.gov/35848380/
  25. Shem K, Barncord S, Flavin K, Mohan M. Adverse cognitive effect of gabapentin in individuals with spinal cord injury: preliminary findings. Spinal Cord Series and Cases 2018 4:1 [Internet]. 2018 Jan 23 [cited 2024 Nov 12];4(1):1–7. Available from: https://www.nature.com/articles/s41394-018-0038-y
  26. Daher A, Cornelissen C, Hartmann NU, Balfanz P, Müller A, Bergs I, et al. Six Months Follow-Up of Patients with Invasive Mechanical Ventilation Due to COVID-19 Related ARDS. International Journal of Environmental Research and Public Health 2021, Vol 18, Page 5861 [Internet]. 2021 May 29 [cited 2023 Dec 1];18(11):5861. Available from: https://www.mdpi.com/1660-4601/18/11/5861/htm
  27. González J, Benítez ID, Carmona P, Santisteve S, Monge A, Moncusí-Moix A, et al. Pulmonary Function and Radiologic Features in Survivors of Critical COVID-19: A 3-Month Prospective Cohort. Chest [Internet]. 2021 Jul 1 [cited 2024 Nov 12];160(1):187–98. Available from: http://journal.chestnet.org/article/S0012369221004645/fulltext
  28. Van Den Borst B, Peters JB, Brink M, Schoon Y, Bleeker-Rovers CP, Schers H, et al. Comprehensive Health Assessment 3 Months After Recovery From Acute Coronavirus Disease 2019 (COVID-19). Clin Infect Dis [Internet]. 2021 Sep 1 [cited 2023 Dec 5];73(5):E1089–98. Available from: https://pubmed.ncbi.nlm.nih.gov/33220049/
  29. Frontera JA, Simon NM. Bridging Knowledge Gaps in the Diagnosis and Management of Neuropsychiatric Sequelae of COVID-19. JAMA Psychiatry [Internet]. 2022 Aug 1 [cited 2023                             Nov                     27];79(8):811–7.                     Available                     from: https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2793903
  30. Zhou X, Snoswell CL, Harding LE, Bambling M, Edirippulige S, Bai X, et al. The Role of Telehealth in Reducing the Mental Health Burden from COVID-19. Telemed J E Health [Internet]. 2020 Apr 1 [cited 2024 Nov 12];26(4):377–9. Available from: https://pubmed.ncbi.nlm.nih.gov/32202977/
  31. Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA Cardiol [Internet]. 2020 Nov 1 [cited 2024 Nov                                    12];5(11):1265–73.                              Available                              from: https://jamanetwork.com/journals/jamacardiology/fullarticle/2768916
  32. Foa Edna, Keane Terence. Effective Treatments for PTSD, Second Edition : Practice Guidelines from the International Society for Traumatic Stress Studies. 2008 [cited 2024 Oct 29];1181.                                                                       Available                                                        from: https://books.google.com/books/about/Effective_Treatments_for_PTSD_Second_Edi.html?hl =ru&id=MFyEg007YEIC
  33. Khoury B, Lecomte T, Fortin G, Masse M, Therien P, Bouchard V, et al. Mindfulness-based therapy: a comprehensive meta-analysis. Clin Psychol Rev [Internet]. 2013 Aug [cited 2024 Nov 12];33(6):763–71. Available from: https://pubmed.ncbi.nlm.nih.gov/23796855/
  34. Mann SK, Marwaha R, Torrico TJ. Posttraumatic Stress Disorder. Clinical Psychology: A Global Perspective [Internet]. 2024 Feb 25 [cited 2024 Nov 12];191–208. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559129/
  35. Czeisler MÉ, Lane RI, Petrosky E, Wiley JF, Christensen A, Njai R, et al. Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic - United States, June 24-30, 2020. MMWR Morb Mortal Wkly Rep [Internet]. 2020 Aug 14 [cited 2024 Nov 12];69(32):1049–57. Available from: https://pubmed.ncbi.nlm.nih.gov/32790653/
  36. Gunnell D, Appleby L, Arensman E, Hawton K, John A, Kapur N, et al. Suicide risk and prevention during the COVID-19 pandemic. Lancet Psychiatry [Internet]. 2020 Jun 1 [cited 2024 Nov 12];7(6):468–71. Available from: https://pubmed.ncbi.nlm.nih.gov/32330430/
  37. Becker JH, Lin JJ, Doernberg M, Stone K, Navis A, Festa JR, et al. Assessment of Cognitive Function in Patients After COVID-19 Infection. JAMA Netw Open [Internet]. 2021 Oct 22 [cited 2024 Nov 12];4(10). Available from: https://pubmed.ncbi.nlm.nih.gov/34677597/
  38. Clinical management of COVID-19: Living guideline, 18 August 2023 [Internet]. [cited 2023 Dec 5]. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical- 2023.2
  39. Korchut A, Rejdak K. Late neurological consequences of SARS-CoV-2 infection: New challenges for the neurologist. Front Neurosci. 2023 Feb 9;17:1004957.
  40. Calabria M, García-Sánchez C, Grunden N, Pons C, Arroyo JA, Gómez-Anson B, et al. Post- COVID-19 fatigue: the contribution of cognitive and neuropsychiatric symptoms. J Neurol [Internet]. 2022 Aug 1 [cited 2024 Nov 12];269(8):3990–9. Available from: https://pubmed.ncbi.nlm.nih.gov/35488918/
  41. Joli J, Buck P, Zipfel S, Stengel A. Post-COVID-19 fatigue: A systematic review. Front Psychiatry. 2022 Aug 11;13:947973.
  42. Morrow AK, Malone LA, Kokorelis C, Petracek LS, Eastin EF, Lobner KL, et al. Long-Term COVID 19 Sequelae in Adolescents: the Overlap with Orthostatic Intolerance and ME/CFS. Curr Pediatr Rep [Internet]. 2022 Jun 1 [cited 2024 Nov 12];10(2):31–44. Available from: https://pubmed.ncbi.nlm.nih.gov/35287333/
  43. Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management. Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management [Internet]. 2021 Oct 29 [cited 2024 Nov 12]; Available from: https://www.ncbi.nlm.nih.gov/books/NBK579533/
  44. Bateman L, Bested AC, Bonilla HF, Chheda B V., Chu L, Curtin JM, et al. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Essentials of Diagnosis and Management. Mayo Clin Proc [Internet]. 2021 Nov 1 [cited 2024 Nov 12];96(11):2861–78. Available from: https://pubmed.ncbi.nlm.nih.gov/34454716/
  45. Kuut TA, Müller F, Csorba I, Braamse A, Aldenkamp A, Appelman B, et al. Efficacy of Cognitive-Behavioral Therapy Targeting Severe Fatigue Following Coronavirus Disease 2019: Results of a Randomized Controlled Trial. Clinical Infectious Diseases [Internet]. 2023 Sep 11 [cited 2024 Nov 12];77(5):687–95. Available from: https://dx.doi.org/10.1093/cid/ciad257
  46. Kim DY, Lee JS, Son CG. Systematic Review of Primary Outcome Measurements for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) in Randomized Controlled Trials. J Clin Med [Internet]. 2020 Oct 28 [cited 2024 Nov 12];9(11):1–12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/33126460
  47. Oliver-Mas S, Delgado-Alonso C, Delgado-Álvarez A, Díez-Cirarda M, Cuevas C, Fernández- Romero L, et al. Transcranial direct current stimulation for post-COVID fatigue: a randomized, double-blind, controlled pilot study. Brain Commun [Internet]. 2023 Mar 2 [cited 2024 Nov 12];5(2). Available from: https://dx.doi.org/10.1093/braincomms/fcad117
  48. Robbins T, Gonevski M, Clark C, Baitule S, Sharma K, Magar A, et al. Hyperbaric oxygen therapy for the treatment of long COVID: early evaluation of a highly promising intervention. Clin Med (Lond) [Internet]. 2021 Nov 1 [cited 2024 Nov 12];21(6):E629–32. Available from: https://pubmed.ncbi.nlm.nih.gov/34862223/
  49. Dayrit JK, Verduzco-Gutierrez M, Teal A, Shah SA. Enhanced External Counterpulsation as a Novel Treatment for Post-acute COVID-19 Sequelae. Cureus [Internet]. 2021 Apr 8 [cited 2024 Nov 12];13(4). Available from: https://pubmed.ncbi.nlm.nih.gov/33987042/
  50. Frontera JA, Guekht A, Allegri RF, Ashraf M, Baykan B, Crivelli L, et al. Evaluation and treatment approaches for neurological post-acute sequelae of COVID-19: A consensus statement and scoping review from the global COVID-19 neuro research coalition. J Neurol Sci [Internet]. 2023 Nov 15 [cited 2024 Oct 2];454. Available from: http://www.jns- journal.com/article/S0022510X23002885/fulltext
  51. Ricci F, Fedorowski A, Radico F, Romanello M, Tatasciore A, Di Nicola M, et al. Cardiovascular morbidity and mortality related to orthostatic hypotension: a meta-analysis of prospective observational studies. Eur Heart J [Internet]. 2015 Jul 1 [cited 2024 Nov 12];36(25):1609–17. Available from: https://dx.doi.org/10.1093/eurheartj/ehv093
  52. Novak P. Autonomic Disorders. Am J Med [Internet]. 2019 Apr 1 [cited 2024 Nov 12];132(4):420–36. Available from: https://pubmed.ncbi.nlm.nih.gov/30308186/
  53. Raj SR, Guzman JC, Harvey P, Richer L, Schondorf R, Seifer C, et al. Canadian Cardiovascular Society Position Statement on Postural Orthostatic Tachycardia Syndrome (POTS) and Related Disorders of Chronic Orthostatic Intolerance. Can J Cardiol [Internet]. 2020 Mar 1 [cited 2024 Nov 12];36(3):357–72. Available from: https://pubmed.ncbi.nlm.nih.gov/32145864/
  54. Thijs RD, Brignole M, Falup-Pecurariu C, Fanciulli A, Freeman R, Guaraldi P, et al. Recommendations for tilt table testing and other provocative cardiovascular autonomic tests in conditions that may cause transient loss of consciousness: Consensus statement of the European Federation of Autonomic Societies (EFAS) endorsed by the American Autonomic Society (AAS) and the European Academy of Neurology (EAN). Clinical Autonomic Research [Internet]. 2021 Jun 1 [cited 2024 Nov 12];31(3):369–84. Available from: https://link.springer.com/article/10.1007/s10286-020-00738-6
  55. Palma JA, Kaufmann H. Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies. Mov Disord [Internet]. 2018 Mar 1 [cited 2024 Nov 12];33(3):372–90. Available from: https://pubmed.ncbi.nlm.nih.gov/29508455/
  56. Coon EA, Singer W, Low PA. Pure Autonomic Failure. Mayo Clin Proc [Internet]. 2019 Oct 1             [cited           2024           Nov           12];94(10):2087–98.            Available            from: https://pubmed.ncbi.nlm.nih.gov/31515103/
  57. Korchut A, Rejdak K. Late neurological consequences of SARS-CoV-2 infection: New challenges for the neurologist. Front Neurosci [Internet]. 2023 Feb 9 [cited 2024 Nov 12];17. Available from: https://pubmed.ncbi.nlm.nih.gov/36845421/
  58. Frontera JA, Guekht A, Allegri RF, Ashraf M, Baykan B, Crivelli L, et al. Evaluation and treatment approaches for neurological post-acute sequelae of COVID-19: A consensus statement and scoping review from the global COVID-19 neuro research coalition. J Neurol Sci [Internet]. 2023 Nov 15 [cited 2024 Sep 30];454. Available from: http://www.jns- journal.com/article/S0022510X23002885/fulltext
  59. Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep [Internet]. 2021 Dec 1 [cited 2024 Nov 12];11(1). Available from: https://pubmed.ncbi.nlm.nih.gov/34373540/
  60. Frontera JA, Thorpe LE, Simon NM, de Havenon A, Yaghi S, Sabadia SB, et al. Post-acute sequelae of COVID-19 symptom phenotypes and therapeutic strategies: A prospective, observational study. PLoS One [Internet]. 2022 Sep 1 [cited 2024 Nov 12];17(9). Available from: https://pubmed.ncbi.nlm.nih.gov/36174032/
  61. García-Azorín D, García-Ruiz C, Sierra-Mencía Á, Gonzalez-Osorio Y, Recio-García A, González-Celestino A, et al. Acute and preventive treatment of COVID-19 related headache: A series of 100 patients. 2022 Jul 21 [cited 2024 Nov 12]; Available from: https://www.researchsquare.com
  62. Üçeyler N, Sommer C, Walitt B, Häuser W. Anticonvulsants for fibromyalgia. Cochrane Database of Systematic Reviews [Internet]. 2013 Oct 16 [cited 2024 Nov 12];2013(10). Available from: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010782/full
  63. Bernardy K, Klose P, Busch AJ, Choy EHS, Häuser W. Cognitive behavioural therapies for fibromyalgia. Cochrane Database Syst Rev [Internet]. 2013 Sep 10 [cited 2024 Nov 12];2013(9). Available from: https://pubmed.ncbi.nlm.nih.gov/24018611/
  64. Kia S, Choy E. Update on Treatment Guideline in Fibromyalgia Syndrome with Focus on Pharmacology. Biomedicines [Internet]. 2017 Jun 1 [cited 2024 Nov 12];5(2). Available from: https://pubmed.ncbi.nlm.nih.gov/28536363/
  65. Macfarlane GJ, Kronisch C, Dean LE, Atzeni F, Häuser W, Flub E, et al. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis [Internet]. 2017 Feb 1 [cited 2024 Nov 12];76(2):318–28. Available from: https://ard.bmj.com/content/76/2/318
  66. Lefaucheur JP, Aleman A, Baeken C, Benninger DH, Brunelin J, Di Lazzaro V, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014-2018). Clin Neurophysiol [Internet]. 2020 Feb 1 [cited 2024 Nov 12];131(2):474–528. Available from: https://pubmed.ncbi.nlm.nih.gov/31901449/
  67. Su YC, Guo YH, Hsieh PC, Lin YC. Efficacy of Repetitive Transcranial Magnetic Stimulation in Fibromyalgia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Clin Med [Internet]. 2021 Oct 1 [cited 2024 Nov 12];10(20). Available from: https://pubmed.ncbi.nlm.nih.gov/34682790/
  68. Lloyd DM, Wittkopf PG, Arendsen LJ, Jones AKP. Is Transcranial Direct Current Stimulation (tDCS) Effective for the Treatment of Pain in Fibromyalgia? A Systematic Review and Meta- Analysis. J Pain [Internet]. 2020 Nov 1 [cited 2024 Nov 12];21(11–12):1085–100. Available from: https://pubmed.ncbi.nlm.nih.gov/31982685/